Medical Properties Trust Inc. (NYSE:MPW) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Wednesday. The brokerage currently has a $16.00 price objective on the real estate investment trust’s stock. Zacks Investment Research’s price target suggests a potential upside of 7.53% from the stock’s current price.

According to Zacks, “Medical Properties Trust, Inc. is a Birmingham, Alabama based self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. These facilities include inpatient rehabilitation hospitals, long-term acute care hospitals, regional and community hospitals, women’s and children’s hospitals, skilled nursing facilities, ambulatory surgery centers, and other single-discipline healthcare facilities, such as heart hospitals, orthopedic hospitals and cancer centers. “

Several other equities research analysts have also issued reports on MPW. TheStreet raised Medical Properties Trust from a “hold” rating to a “buy” rating in a research note on Tuesday, June 21st. Deutsche Bank AG initiated coverage on Medical Properties Trust in a research note on Friday, July 22nd. They set a “buy” rating and a $17.00 price target for the company. Wells Fargo & Co. reaffirmed a “hold” rating on shares of Medical Properties Trust in a research note on Sunday, September 4th. JMP Securities lowered Medical Properties Trust from an “outperform” rating to a “market perform” rating in a research note on Friday, July 1st. Finally, BTIG Research initiated coverage on Medical Properties Trust in a research note on Thursday, August 25th. They set a “neutral” rating for the company. Five analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $14.17.

Shares of Medical Properties Trust (NYSE:MPW) opened at 14.88 on Wednesday. Medical Properties Trust has a 1-year low of $9.61 and a 1-year high of $15.92. The company’s 50-day moving average price is $15.02 and its 200 day moving average price is $14.35. The firm has a market cap of $3.54 billion, a PE ratio of 18.19 and a beta of 1.02.

Medical Properties Trust (NYSE:MPW) last posted its quarterly earnings data on Thursday, August 4th. The real estate investment trust reported $0.32 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.32. The company earned $126.30 million during the quarter, compared to analyst estimates of $128.04 million. Medical Properties Trust had a return on equity of 9.06% and a net margin of 38.03%. The firm’s quarterly revenue was up 26.6% on a year-over-year basis. During the same quarter last year, the company earned $0.30 earnings per share. On average, analysts predict that Medical Properties Trust will post $1.30 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Thursday, October 13th. Stockholders of record on Thursday, September 15th will be paid a $0.23 dividend. This represents a $0.92 dividend on an annualized basis and a dividend yield of 6.18%. The ex-dividend date of this dividend is Tuesday, September 13th. Medical Properties Trust’s dividend payout ratio (DPR) is presently 115.00%.

In other news, Chairman Edward K. Aldag, Jr. sold 50,000 shares of the business’s stock in a transaction dated Tuesday, August 9th. The stock was sold at an average price of $15.52, for a total value of $776,000.00. Following the completion of the sale, the chairman now owns 1,927,313 shares of the company’s stock, valued at approximately $29,911,897.76. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director G Steven Dawson sold 10,000 shares of the business’s stock in a transaction dated Friday, August 19th. The shares were sold at an average price of $15.36, for a total value of $153,600.00. Following the completion of the sale, the director now directly owns 67,729 shares of the company’s stock, valued at approximately $1,040,317.44. The disclosure for this sale can be found here. 1.44% of the stock is owned by insiders.

Large investors have recently added to or reduced their stakes in the stock. BlackRock Japan Co. Ltd raised its stake in Medical Properties Trust by 0.5% in the first quarter. BlackRock Japan Co. Ltd now owns 12,577 shares of the real estate investment trust’s stock worth $163,000 after buying an additional 65 shares during the period. Daiwa Securities Group Inc. raised its stake in Medical Properties Trust by 1.2% in the second quarter. Daiwa Securities Group Inc. now owns 8,500 shares of the real estate investment trust’s stock worth $129,000 after buying an additional 100 shares during the period. MCF Advisors LLC raised its stake in Medical Properties Trust by 1.6% in the second quarter. MCF Advisors LLC now owns 8,397 shares of the real estate investment trust’s stock worth $128,000 after buying an additional 136 shares during the period. Keeley Asset Management Corp raised its stake in Medical Properties Trust by 0.3% in the second quarter. Keeley Asset Management Corp now owns 73,658 shares of the real estate investment trust’s stock worth $1,120,000 after buying an additional 191 shares during the period. Finally, Advisory Services Network LLC raised its stake in Medical Properties Trust by 2.8% in the second quarter. Advisory Services Network LLC now owns 12,337 shares of the real estate investment trust’s stock worth $188,000 after buying an additional 337 shares during the period. 81.48% of the stock is owned by institutional investors.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust (REIT) focused on investing in and owning net-leased healthcare facilities. It conducts all of its business through MPT Operating Partnership, L.P. It acquires and develops healthcare facilities and leases the facilities to healthcare operating companies under long-term net leases.

5 Day Chart for NYSE:MPW

Get a free copy of the Zacks research report on Medical Properties Trust (MPW)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Medical Properties Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust Inc. and related companies with MarketBeat.com's FREE daily email newsletter.